The Roles of the RIIβ Linker and N-terminal Cyclic Nucleotide-binding Domain in Determining the Unique Structures of the Type IIβ Protein Kinase A

Donald K. Blumenthal,Jeffrey Copps,Eric V. Smith-Nguyen,Ping Zhang,William T. Heller,Susan S. Taylor
DOI: https://doi.org/10.1074/jbc.m114.584177
IF: 5.485
2014-01-01
Journal of Biological Chemistry
Abstract:Protein kinase A (PKA) is ubiquitously expressed and is responsible for regulating many important cellular functions in response to changes in intracellular cAMP concentrations. The PKA holoenzyme is a tetramer (R-2:C-2), with a regulatory subunit homodimer (R-2) that binds and inhibits two catalytic (C) subunits; binding of cAMP to the regulatory subunit homodimer causes activation of the catalytic subunits. Four different R subunit isoforms exist in mammalian cells, and these confer different structural features, subcellular localization, and biochemical properties upon the PKA holoenzymes they form. The holoenzyme containing RII beta is structurally unique in that the type II beta holoenzyme is much more compact than the free RII beta homodimer. We have used small angle x-ray scattering and small angle neutron scattering to study the solution structure and subunit organization of a holoenzyme containing an RII beta C-terminal deletion mutant (RII beta (1-280)), which is missing the C-terminal cAMP-binding domain to better understand the structural organization of the type II beta holoenzyme and the RII beta domains that contribute to stabilizing the holoenzyme conformation. Our results demonstrate that compaction of the type II beta holoenzyme does not require the C-terminal cAMP-binding domain but rather involves large structural rearrangements within the linker and N-terminal cyclic nucleotide-binding domain of the RII beta homodimer. The structural rearrangements are significantly greater than seen previously with RII beta and are likely to be important in mediating short range and long range interdomain and intersubunit interactions that uniquely regulate the activity of the type II beta isoform of PKA.
What problem does this paper attempt to address?